Lawson Health Research Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lawson Health Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10699
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lawson Health Research Institute (Lawson) is a hospital-based research institute that offers educational and research programs. The institute’ services include health research programs, medical research programs, educational research programs, scientific research programs, patient care services, medical care, clinical trials and healthcare services. It also provides surgical technologies and advanced robotics services, clinical research, cancer research, clinical investigations and therapeutics, cyclotron and pet radiochemistry, kidney clinical research, renal health discovery and translation services. Lawson offers cancer research laboratory programs, children’s health research, diabetes and endocrinology, critical illness, mental health research, imaging and microbiome and probiotics services, among others. The institution provides its services through its centers, facilities and medical departments. Lawson is headquartered in London, Ontario, Canada.

Lawson Health Research Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lawson Health Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
StemCell Technologies Enters into Licensing Agreement with Lawson Health Research Institute 10
Yabao Pharma Enters into Licensing Agreement with Lawson Health Research Institute 11
Novare Pharma Enters into Licensing Agreement with Lawson Health Research Institute 12
Lawson Health Research Institute – Key Competitors 13
Lawson Health Research Institute – Key Employees 14
Lawson Health Research Institute – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Government and Public Interest 16
Oct 24, 2018: New clinical protocol after general surgery cuts opioid prescribing in half 16
Jul 11, 2018: Health researchers in London bring in over $11 million of national funding 17
May 03, 2018: Researchers find gut microbiome plays an important role in atherosclerosis 18
Apr 25, 2018: How the brain is folded provides researchers with an accurate marker to predict psychosis in high-risk patients 19
Mar 05, 2018: Early psychosis programs significantly reduce patient mortality, study finds 20
Feb 26, 2018: Lawson researchers receive $4.4 million to study personalized medicine at LHSC 22
Jan 29, 2018: New radiation techniques could improve quality of life for lung cancer patients 24
Jan 25, 2018: London researchers net over $8.6 million in CIHR funding 25
Other Significant Developments 26
Jul 09, 2018: Synthetic surfactant could ease breathing for patients with lung disease and injury 26
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Key Facts 2
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lawson Health Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lawson Health Research Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
StemCell Technologies Enters into Licensing Agreement with Lawson Health Research Institute 10
Yabao Pharma Enters into Licensing Agreement with Lawson Health Research Institute 11
Novare Pharma Enters into Licensing Agreement with Lawson Health Research Institute 12
Lawson Health Research Institute, Key Competitors 13
Lawson Health Research Institute, Key Employees 14

List of Figures
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Lawson Health Research Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Altice Europe Nv
    Altice Europe Nv - Strategy, SWOT and Corporate Finance Report Summary Altice Europe Nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Leon’s Furniture Ltd (LNF):企業の財務・戦略的SWOT分析
    Leon's Furniture Ltd (LNF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Ctrip.Com International Ltd
    Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report Summary Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Ascent Solar Technologies Inc (ASTI)-エネルギー分野:企業M&A・提携分析
    Summary Ascent Solar Technologies, Inc. (Ascent solar) is a developer and manufacturer of thin-film photovoltaic modules using substrate materials. It develops products by using thin-film copper-indium-gallium- diselenide (CIGS) photovoltaic technology. The product portfolio of the company includes …
  • The Toyama Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Toyama Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Toyama Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Stada Arzneimittel AG (SAZ):医療機器:M&Aディール及び事業提携情報
    Summary Stada Arzneimittel AG (STADA) is a manufacturer of low-cost generics and branded over the counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It offers a portfolio of product …
  • Medivir AB (MVIR B):企業の財務・戦略的SWOT分析
    Summary Medivir AB (Medivir) is a drug discovery and development company focusing on transformative cancer drugs. The company offers products under development for the treatment of cutaneous T-cell lymphoma, osteoarthritis, solid tumors, hepatocellular carcinoma and RSV-infection. Medivir also provi …
  • Neuland Laboratories Ltd (NEULANDLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Neuland Laboratories Ltd (Neuland Lab), a subsidiary of Neuland Health Sciences Pvt Ltd is an API manufacturing service provider that manufactures active pharmaceutical ingredients, advanced intermediates; and offers chemistry related services. The company provides APIs in various therapeuti …
  • Natera Inc (NTRA):企業の製品パイプライン分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers Panorama, a non-invasive prenatal screening test that analyzes baby's DNA through a simple blood dra …
  • Equity Assurance plc:企業の戦略・SWOT・財務情報
    Equity Assurance plc - Strategy, SWOT and Corporate Finance Report Summary Equity Assurance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • California Cryobank:製薬・医療:M&Aディール及び事業提携情報
    Summary California Cryobank (CCB) is a healthcare service provider that offers reproductive, stem cell and donor selection services. The center offers services such as donor semen, pricing, donor information subscriptions, graduate donors, donor information, consultation services, genetic services, …
  • LPP SA (LPP):企業の財務・戦略的SWOT分析
    LPP SA (LPP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • CMA CGM SA:企業のM&A・事業提携・投資動向
    CMA CGM SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CMA CGM SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Medicure Inc (MPH):企業の財務・戦略的SWOT分析
    Summary Medicure Inc (Medicure) is a pharmaceutical company that strives to research, develop and commercialize therapeutics for cardiovascular diseases. The company offers products such as Aggrastat, a glycoprotein GP IIb/IIIa receptor antagonist indicated for the treatment of acute coronary syndro …
  • NorthStar Realty Finance Corp:企業のM&A・事業提携・投資動向
    NorthStar Realty Finance Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NorthStar Realty Finance Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • AGL Energy Ltd (AGL)-エネルギー分野:企業M&A・提携分析
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …
  • Cibis SpA:企業の戦略・SWOT・財務分析
    Cibis SpA - Strategy, SWOT and Corporate Finance Report Summary Cibis SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • EBOS Group Ltd (EBO):製薬・医療:M&Aディール及び事業提携情報
    Summary EBOS Group Ltd (EBOS) is a healthcare products supplier that markets, sells and distributes healthcare, medical and pharmaceutical products. It also markets and distributes animal care products and offers distribution, warehousing and logistics support to pharmaceutical manufacturers and med …
  • Millendo Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Millendo Therapeutics Inc (Millendo Therapeutics), formerly Atterocor Inc is a drug development company that develops treatments for endocrine diseases including vasomotor. The company provides development of innovative treatments for orphan endocrine disorders such as adrenocortical carcino …
  • Damco International B.V.:企業の戦略・SWOT・財務分析
    Damco International B.V. - Strategy, SWOT and Corporate Finance Report Summary Damco International B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆